Stay updated on AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Sign up to get notified when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.

Latest updates to the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page
- Check4 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site revision marker changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check32 days agoChange DetectedAn NIH notice about terminology changes during a website transition appears, and the site revision advances from v3.7.1 to v3.7.2. The study record itself is unchanged.SummaryDifference0.9%

- Check46 days agoChange DetectedThe website footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check67 days agoChange DetectedA new revision entry (v3.7.0) was added to the study record history, and the older revision (v3.6.6) was removed, reflecting an update to the record’s version history.SummaryDifference0.1%

- Check81 days agoChange DetectedThe history shows a new release entry 'Revision: v3.6.6' added and the older 'Revision: v3.6.5' removed. This reflects a software or site version update applied to the page.SummaryDifference0.1%

Stay in the know with updates to AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.